CZ2003156A3 - Způsob vyhledávání sloučenin, které jsou vhodné pro léčení a/nebo profylaxi obezity - Google Patents
Způsob vyhledávání sloučenin, které jsou vhodné pro léčení a/nebo profylaxi obezity Download PDFInfo
- Publication number
- CZ2003156A3 CZ2003156A3 CZ2003156A CZ2003156A CZ2003156A3 CZ 2003156 A3 CZ2003156 A3 CZ 2003156A3 CZ 2003156 A CZ2003156 A CZ 2003156A CZ 2003156 A CZ2003156 A CZ 2003156A CZ 2003156 A3 CZ2003156 A3 CZ 2003156A3
- Authority
- CZ
- Czechia
- Prior art keywords
- compounds
- obesity
- prophylaxis
- treatment
- ability
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10035227A DE10035227A1 (de) | 2000-07-20 | 2000-07-20 | Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ2003156A3 true CZ2003156A3 (cs) | 2003-06-18 |
Family
ID=7649538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ2003156A CZ2003156A3 (cs) | 2000-07-20 | 2001-07-12 | Způsob vyhledávání sloučenin, které jsou vhodné pro léčení a/nebo profylaxi obezity |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1307262B1 (sk) |
JP (1) | JP2004504053A (sk) |
KR (1) | KR100818827B1 (sk) |
CN (1) | CN1443085B (sk) |
AR (1) | AR028730A1 (sk) |
AT (1) | ATE278441T1 (sk) |
AU (2) | AU2001277534B9 (sk) |
BR (1) | BR0112547A (sk) |
CA (1) | CA2416647A1 (sk) |
CZ (1) | CZ2003156A3 (sk) |
DE (2) | DE10035227A1 (sk) |
DZ (1) | DZ3393A1 (sk) |
ES (1) | ES2230346T3 (sk) |
HK (1) | HK1057499A1 (sk) |
HU (1) | HUP0302309A3 (sk) |
IL (2) | IL153971A0 (sk) |
MX (1) | MXPA02012907A (sk) |
NO (1) | NO20030233L (sk) |
NZ (1) | NZ523960A (sk) |
PL (1) | PL201165B1 (sk) |
PT (1) | PT1307262E (sk) |
RU (1) | RU2268721C2 (sk) |
SK (1) | SK287607B6 (sk) |
TR (1) | TR200402670T4 (sk) |
TW (1) | TWI274157B (sk) |
UA (1) | UA74588C2 (sk) |
WO (1) | WO2002007821A1 (sk) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1750712A2 (en) | 2004-05-19 | 2007-02-14 | Solvay Pharmaceuticals GmbH | Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
WO2006127184A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
TW200804393A (en) | 2005-11-14 | 2008-01-16 | Solvay Pharm Gmbh | Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
AR058389A1 (es) * | 2005-12-19 | 2008-01-30 | Janssen Pharmaceutica Nv | Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
AU2007253814A1 (en) | 2006-05-19 | 2007-11-29 | Janssen Pharmaceutica N.V. | Co-therapy for the treatment of epilepsy |
PL2106260T3 (pl) | 2007-01-25 | 2018-06-29 | NAIA Metabolic, Inc. | Środki uwrażliwiające na insulinę i sposoby leczenia |
AU2009271362B2 (en) | 2008-06-23 | 2014-03-13 | Janssen Pharmaceutica Nv | Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
US20150150855A1 (en) * | 2012-05-24 | 2015-06-04 | Verva Pharmaceuticals Ltd | Method of improving liver function |
CN106770611B (zh) * | 2016-12-22 | 2019-01-29 | 广西师范大学 | 一种用于细胞原位检测小分子化合物进入线粒体的方法 |
RU2771430C1 (ru) * | 2021-09-21 | 2022-05-04 | Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) | Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552897A (en) * | 1983-02-01 | 1985-11-12 | American Cyanamid Company | Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom |
US6288095B1 (en) * | 1987-09-04 | 2001-09-11 | Beecham Group P.L.C. | Compounds |
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
MD1486G2 (ro) * | 1992-10-29 | 2001-11-30 | Genentech, Inc. | Metodă de tratament sau profilaxie a obezităţii |
AU693478B2 (en) * | 1994-11-10 | 1998-07-02 | Metabolic Pharmaceuticals Limited | Treatment of obesity |
CN1106193C (zh) * | 1996-06-28 | 2003-04-23 | 奥索·麦克尼尔药品公司 | 抗惊厥剂氨基磺酸酯衍生物用于治疗肥胖的用途 |
US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
-
2000
- 2000-07-20 DE DE10035227A patent/DE10035227A1/de not_active Withdrawn
-
2001
- 2001-06-15 AR ARP010102883A patent/AR028730A1/es unknown
- 2001-07-12 CN CN018129730A patent/CN1443085B/zh not_active Expired - Fee Related
- 2001-07-12 JP JP2002513551A patent/JP2004504053A/ja active Pending
- 2001-07-12 AT AT01955345T patent/ATE278441T1/de active
- 2001-07-12 IL IL15397101A patent/IL153971A0/xx unknown
- 2001-07-12 TR TR2004/02670T patent/TR200402670T4/xx unknown
- 2001-07-12 HU HU0302309A patent/HUP0302309A3/hu unknown
- 2001-07-12 DE DE50104023T patent/DE50104023D1/de not_active Expired - Lifetime
- 2001-07-12 KR KR1020037000620A patent/KR100818827B1/ko not_active IP Right Cessation
- 2001-07-12 WO PCT/EP2001/008051 patent/WO2002007821A1/de active IP Right Grant
- 2001-07-12 BR BR0112547-8A patent/BR0112547A/pt not_active Application Discontinuation
- 2001-07-12 DZ DZ013393A patent/DZ3393A1/xx active
- 2001-07-12 EP EP01955345A patent/EP1307262B1/de not_active Expired - Lifetime
- 2001-07-12 SK SK61-2003A patent/SK287607B6/sk not_active IP Right Cessation
- 2001-07-12 NZ NZ52396001A patent/NZ523960A/xx not_active IP Right Cessation
- 2001-07-12 PL PL363518A patent/PL201165B1/pl not_active IP Right Cessation
- 2001-07-12 RU RU2003104803/14A patent/RU2268721C2/ru not_active IP Right Cessation
- 2001-07-12 CA CA002416647A patent/CA2416647A1/en not_active Abandoned
- 2001-07-12 ES ES01955345T patent/ES2230346T3/es not_active Expired - Lifetime
- 2001-07-12 CZ CZ2003156A patent/CZ2003156A3/cs unknown
- 2001-07-12 AU AU2001277534A patent/AU2001277534B9/en not_active Ceased
- 2001-07-12 MX MXPA02012907A patent/MXPA02012907A/es active IP Right Grant
- 2001-07-12 AU AU7753401A patent/AU7753401A/xx active Pending
- 2001-07-12 PT PT01955345T patent/PT1307262E/pt unknown
- 2001-07-16 TW TW090117382A patent/TWI274157B/zh not_active IP Right Cessation
- 2001-12-07 UA UA2003021453A patent/UA74588C2/uk unknown
-
2003
- 2003-01-15 IL IL153971A patent/IL153971A/en not_active IP Right Cessation
- 2003-01-17 NO NO20030233A patent/NO20030233L/no unknown
-
2004
- 2004-01-15 HK HK04100307.4A patent/HK1057499A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CZ2003156A3 (cs) | Způsob vyhledávání sloučenin, které jsou vhodné pro léčení a/nebo profylaxi obezity | |
Jeppesen et al. | Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat | |
Matsuzawa-Nagata et al. | Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity | |
Sreekumar et al. | Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis | |
US6946243B2 (en) | Method of identifying compounds suitable for treatment and/or prophylaxis of obesity | |
Johnson et al. | Alcohol–medical drug interactions | |
Matthysse et al. | S-adenosylmethionine and catechol-O-methyltransferase in schizophrenia | |
Haas et al. | Inherited disorders of cholesterol biosynthesis | |
Vieira‐Coelho et al. | Ontogenic aspects of liver and kidney catechol‐O‐methyltransferase sensitivity to tolcapone | |
Walker et al. | NAD (H) in mitochondrial energy transduction: implications for health and disease | |
Maeda et al. | Biotin deficiency decreases ornithine transcarbamylase activity and mRNA in rat liver | |
Lin et al. | Benzylamine and methylamine, substrates of semicarbazide-sensitive amine oxidase, attenuate inflammatory response induced by lipopolysaccharide | |
Deitrich et al. | Effect of administered ethanol on protein kinase C in human platelets | |
Takabe et al. | Gene expression induced by BO-653, probucol and BHQ in human endothelial cells | |
Kosel et al. | In vitro metabolism of citalopram by monoamine oxidase B in human blood | |
KR20110054880A (ko) | 알콜해독 및 숙취해소용 해양심층수 함유 키토산올리고당 | |
ZA200300444B (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity. | |
Lee et al. | Rat malonyl-CoA decarboxylase; cloning, expression in E. coli and its biochemical characterization | |
RU2231069C1 (ru) | Способ прогноза течения кишечных инфекций у детей 1-3 лет | |
Tripathi et al. | Mechanism of fenvalerate-withdrawal-dependent recovery in metabolism of a catfish, Clarias batrachus | |
Sandler et al. | Tyramine and depressive illness | |
Hristovska et al. | CORRELATION OF NIACIN, NAD AND NADP CONCENTRATION IN BLOOD ASSOCIATED WITH LIPOLYSIS IN PERIPARTAL DAIRY COWS | |
Henningsson | Radioenzymatic Assay for measurement of SSAO-activity in Human Plasma | |
Fuller | Factors influencing glycogen branching enzyme activity in mouse liver | |
LOWER et al. | FINAL ACCEPTED VERSION G-00509-2004. R1 |